Cargando…
The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030
BACKGROUND: Onchocerciasis (“river blindness”) can cause severe morbidity, including vision loss and various skin manifestations, and is targeted for elimination using ivermectin mass drug administration (MDA). We calculated the number of people with Onchocerca volvulus infection and onchocercal ski...
Autores principales: | Vinkeles Melchers, Natalie V. S., Stolk, Wilma A., van Loon, Welmoed, Pedrique, Belén, Bakker, Roel, Murdoch, Michele E., de Vlas, Sake J., Coffeng, Luc E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8312930/ https://www.ncbi.nlm.nih.gov/pubmed/34310602 http://dx.doi.org/10.1371/journal.pntd.0009604 |
Ejemplares similares
-
How does onchocerciasis-related skin and eye disease in Africa depend on cumulative exposure to infection and mass treatment?
por: Vinkeles Melchers, Natalie V. S., et al.
Publicado: (2021) -
Burden of onchocerciasis-associated epilepsy: first estimates and research priorities
por: Vinkeles Melchers, Natalie V. S., et al.
Publicado: (2018) -
Elimination of African Onchocerciasis: Modeling the Impact of Increasing the Frequency of Ivermectin Mass Treatment
por: Coffeng, Luc E., et al.
Publicado: (2014) -
Projected Number of People With Onchocerciasis–Loiasis Coinfection in Africa, 1995 to 2025
por: Vinkeles Melchers, Natalie V S, et al.
Publicado: (2020) -
The impact of mass drug administration expansion to low onchocerciasis prevalence settings in case of connected villages
por: de Vos, Anneke S., et al.
Publicado: (2021)